3E013TZ
3E013TZ — Introduction of Destructive Agent into Subcutaneous Tissue, Percutaneous Approach
Billable / specific codeICD-10-PCS
CMS abbreviated title: Introduction of Destructive Agent into Subcu, Perc Approach
How 3E013TZ is built
Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.
- 3SectionAdministration — What family of procedure this is
- EBody systemWhich system it acts on
- 0Root operationThe objective — the verb of the procedure
- 1Body partThe specific site
- 3ApproachHow the site was reached
- TDeviceWhat was left in place, if anything
- ZQualifierA further distinction where one applies
Codes near 3E013TZ
In CMS’s own ordering, which groups codes that differ by only the last character or two — usually the approach, device or qualifier.
- 3E0134ZIntroduction of Serum, Toxoid and Vaccine into Subcutaneous Tissue, Percutaneous Approach
- 3E0136ZIntroduction of Nutritional Substance into Subcutaneous Tissue, Percutaneous Approach
- 3E0137ZIntroduction of Electrolytic and Water Balance Substance into Subcutaneous Tissue, Percutaneous Approach
- 3E013BZIntroduction of Anesthetic Agent into Subcutaneous Tissue, Percutaneous Approach
- 3E013GCIntroduction of Other Therapeutic Substance into Subcutaneous Tissue, Percutaneous Approach
- 3E013HZIntroduction of Radioactive Substance into Subcutaneous Tissue, Percutaneous Approach
- 3E013KZIntroduction of Other Diagnostic Substance into Subcutaneous Tissue, Percutaneous Approach
- 3E013NZIntroduction of Analgesics, Hypnotics, Sedatives into Subcutaneous Tissue, Percutaneous Approach
- 3E013TZIntroduction of Destructive Agent into Subcutaneous Tissue, Percutaneous Approach
- 3E013VGIntroduction of Insulin into Subcutaneous Tissue, Percutaneous Approach
- 3E013VJIntroduction of Other Hormone into Subcutaneous Tissue, Percutaneous Approach
- 3E02305Introduction of Other Antineoplastic into Muscle, Percutaneous Approach
- 3E0230MIntroduction of Antineoplastic, Monoclonal Antibody, into Muscle, Percutaneous Approach
- 3E02328Introduction of Oxazolidinones into Muscle, Percutaneous Approach
- 3E02329Introduction of Other Anti-infective into Muscle, Percutaneous Approach
- 3E0233ZIntroduction of Anti-inflammatory into Muscle, Percutaneous Approach
- 3E02340Introduction of Influenza Vaccine into Muscle, Percutaneous Approach